Market Overview:
The global drugs for ophthalmology market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of eye diseases, rising geriatric population, and technological advancements in ophthalmic devices. Based on type, the global drugs for ophthalmology market is segmented into gels, eye solutions, capsules & tablets, eye drops, and ointments. The capsules & tablets segment is expected to grow at the highest CAGR during the forecast period from 2018 to 2030. This growth can be attributed to an increase in demand for combination therapies and growing preference for oral medications over other forms of drug delivery. Based on application, the global drugs for ophthalmology market is segmented into hospital and retail pharmacy segments.
Product Definition:
Drugs for Ophthalmology are used to treat eye diseases. They can be used to prevent or treat infection, inflammation, and other conditions.
Gels:
Gels are a group of compounds that are soluble in water and possess the ability to dissolve several minerals. The most commonly used gels for ophthalmic use include acetic acid, formaldehyde, glyoxylic acid, and sodium tetradecyl sulphate (Sts). These gels act as an irritant on the cornea; therefore it is important to keep them out of reach from the eye.
Eye Solutions:
The global eye solutions and it's usage in drugs for ophthalmology market size was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of age-related ophthalmic disorders such as myopia, hyperopia, presbyopia, cataract & blindness is anticipated to drive the growth during the forecast period.
Application Insights:
Retail pharmacies held the largest share of over 70.0% in 2017. The growing preference for self-medication among consumers is expected to have a positive impact on the growth of this segment during the forecast period. Increasing prevalence of ophthalmic diseases and rising geriatric population are some of the factors responsible for high product demand in this segment.
The hospital application segment is expected to witness significant growth during the forecast period owing to increasing government expenditure on healthcare, especially in developing countries like India and China, which has resulted in growing utilization rates of drugs for ophthalmology at hospitals. In addition, presence or absence of insurance coverage will not affect consumer purchasing behavior regarding these drugs as they can be obtained at nominal cost through private health plans or public programs such as Medicaid and Medicare (U.S.).
Regional Analysis:
North America held the largest share in 2017 owing to the presence of a large number of key players and well-established healthcare infrastructure. Moreover, high adoption rate of novel drugs for ophthalmology treatment coupled with rising prevalence of eye disorders is expected to drive growth. Increasing geriatric population and awareness about early diagnosis are also contributing toward market growth in this region.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period due to increasing disposable income, improving healthcare facilities along with growing target population base especially in India & China. Furthermore, government initiatives such as “Make in India†initiative by Indian government are expected favorably impact industry expansion over next few years. ‰vitamins A & D help maintain healthy eyesight; they may be obtained from animal sources (such as milk) or from plant sources (such as carrots).
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The global population is aging, and with this, the prevalence of eye diseases and disorders is also increasing. This will drive the demand for drugs for ophthalmology market in the coming years.
- Technological advancements in drug delivery systems: Drug delivery systems are evolving rapidly, with new technologies being developed to improve drug absorption and distribution into the target tissues. This will help to improve treatment outcomes for patients suffering from eye diseases and disorders, thereby driving growth in the drugs for ophthalmology market.
- Rising awareness about eye health: There is a growing awareness among people about the importance of maintaining good eye health. This is leading to an increase in demand for effective treatments for various eye conditions, which will spur growth in the drugs for ophthalmology market over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drugs for Ophthalmology Market Research Report
By Type
Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments
By Application
Hospital, Retail Pharmacy
By Companies
Allergan, Aerie Pharmaceuticals, Pfizer, Valeant, Bayer, Genentech, Novartis, Regeneron, Takeda, Santen Pharmaceutical, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Drugs for Ophthalmology Market Report Segments:
The global Drugs for Ophthalmology market is segmented on the basis of:
Types
Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Retail Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Aerie Pharmaceuticals
- Pfizer
- Valeant
- Bayer
- Genentech
- Novartis
- Regeneron
- Takeda
- Santen Pharmaceutical
- Allergan
Highlights of The Drugs for Ophthalmology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gels
- Eye Solutions
- Capsules & Tablets
- Eye Drops
- Ointments
- By Application:
- Hospital
- Retail Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drugs for Ophthalmology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drugs for ophthalmology are medications used to treat various eye conditions. These drugs can be prescribed by a doctor, purchased over the counter, or obtained through a pharmacy.
Some of the major companies in the drugs for ophthalmology market are Allergan, Aerie Pharmaceuticals, Pfizer, Valeant, Bayer, Genentech, Novartis, Regeneron, Takeda, Santen Pharmaceutical, Allergan.
The drugs for ophthalmology market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drugs for Ophthalmology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drugs for Ophthalmology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drugs for Ophthalmology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drugs for Ophthalmology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drugs for Ophthalmology Market Size & Forecast, 2020-2028
4.5.1 Drugs for Ophthalmology Market Size and Y-o-Y Growth
4.5.2 Drugs for Ophthalmology Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Gels
5.2.2 Eye Solutions
5.2.3 Capsules & Tablets
5.2.4 Eye Drops
5.2.5 Ointments
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drugs for Ophthalmology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drugs for Ophthalmology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Gels
9.6.2 Eye Solutions
9.6.3 Capsules & Tablets
9.6.4 Eye Drops
9.6.5 Ointments
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Retail Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Gels
10.6.2 Eye Solutions
10.6.3 Capsules & Tablets
10.6.4 Eye Drops
10.6.5 Ointments
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Retail Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Gels
11.6.2 Eye Solutions
11.6.3 Capsules & Tablets
11.6.4 Eye Drops
11.6.5 Ointments
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Retail Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Gels
12.6.2 Eye Solutions
12.6.3 Capsules & Tablets
12.6.4 Eye Drops
12.6.5 Ointments
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Retail Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Gels
13.6.2 Eye Solutions
13.6.3 Capsules & Tablets
13.6.4 Eye Drops
13.6.5 Ointments
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Retail Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drugs for Ophthalmology Market: Competitive Dashboard
14.2 Global Drugs for Ophthalmology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Aerie Pharmaceuticals
14.3.3 Pfizer
14.3.4 Valeant
14.3.5 Bayer
14.3.6 Genentech
14.3.7 Novartis
14.3.8 Regeneron
14.3.9 Takeda
14.3.10 Santen Pharmaceutical
14.3.11 Allergan
